Benitec Biopharma Growth Metrics (2019-2025) | BNTC

Growth Metrics Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Growth Ratios
EBITDA Margin Growth (1y) -0.02M-30.21M-38.26M-19.95M28.49M38.60M-2.03M-0.08M
EBITDA Margin Growth (3y) -3.75M0.27M-7.24M
EBITDA Margin (QoQ) 0.21M-0.84M1.69M-1.08M-29.98M-8.89M20.00M1.22M3.17M-5.82M
EBIT Margin Growth (1y) -0.14M-32.32M-37.18M-20.10M30.66M37.21M-2.07M-0.08M
EBIT Margin Growth (3y) -3.73M-0.05M-7.32M
EBIT Margin (QoQ) 0.08M-0.48M1.58M-1.31M-32.10M-5.34M18.66M1.21M3.20M-5.70M
EBT Margin Growth (1y) -0.14M-32.34M-37.20M-20.10M30.67M37.23M-2.08M-0.08M
EBT Margin Growth (3y) -3.74M-0.06M-7.33M
EBT Margin (QoQ) 0.08M-0.48M1.57M-1.31M-32.12M-5.34M18.67M1.22M3.21M-5.71M
Enterprise Value Growth (1y) 105.98%93.47%201.99%280.90%3,630.08%2,847.09%23.12%-9.01%-60.26%-200.47%-163.81%-107.09%-22.57%-34.83%-108.92%1,935.60%247.79%259.77%1,875.12%1,381.60%1,958.61%
Enterprise Value Growth (3y) 42.39%-21.69%7.12%51.14%125.56%-233.87%-53.84%5.79%2.28%29.35%187.09%168.13%281.29%
Enterprise Value Growth (5y) 34.42%42.53%99.64%102.12%282.77%
Enterprise Value (QoQ) -23.04%3.54%12.20%105.74%-234.27%1,606.87%55.73%18.38%-1.11%-32.46%15.09%-48.30%-350.03%57.11%87.22%664.76%-535.41%33.55%212.33%7.00%100.02%638.36%-6.25%48.68%
FCF Margin Growth (1y) -0.30M-34.34M-19.88M-25.86M33.41M19.44M-2.85M-0.03M
FCF Margin Growth (3y) -3.78M-0.47M-6.75M
FCF Margin (QoQ) -0.23M0.12M1.18M-1.37M-34.27M14.59M-4.80M0.62M3.44M-5.11M
Gross Margin Growth (1y) -0.02M-0.15M-0.05M0.01M
Gross Margin (QoQ) -0.03M0.02M0.00M-0.01M-0.17M0.12M0.07M
Net Margin Growth (1y) -0.14M-32.34M-37.20M-20.10M30.67M37.23M-2.08M-0.08M
Net Margin Growth (3y) -3.74M-0.06M-7.33M
Net Margin (QoQ) 0.08M-0.48M1.57M-1.31M-32.12M-5.34M18.67M1.22M3.21M-5.71M
Operating Margin Growth (1y) -0.14M-32.32M-37.18M-20.10M30.66M37.21M-2.07M-0.08M
Operating Margin Growth (3y) -3.73M-0.05M-7.32M
Operating Margin (QoQ) 0.08M-0.48M1.58M-1.31M-32.10M-5.34M18.66M1.21M3.20M-5.70M
Return on Assets Growth (1y) 15.00-19.00-54.00-145.00-66.00-14.00-51.00-78.0017.0033.0073.00237.0095.0057.0081.00
Return on Assets Growth (3y) -34.000.00M-31.0014.0046.0076.00104.00
Return on Assets (QoQ) 6.002.009.00-2.00-29.00-32.00-82.0077.0024.00-69.00-110.00172.0040.00-29.0054.0030.002.00-5.00
Return on Capital Employed Growth (1y) 19.00-33.00-63.00-241.00-108.00-18.00-111.00-482.0013.0029.00133.00729.00141.0080.00102.00
Return on Capital Employed Growth (3y) -75.00-22.00-41.006.0047.0092.00124.00
Return on Capital Employed (QoQ) 10.00-9.0020.00-3.00-41.00-39.00-158.00130.0048.00-132.00-528.00626.0064.00-28.0067.0038.003.00-7.00
Return on Equity Growth (1y) -15.0020.00-34.00-86.00-256.00-113.00-24.00-96.00-434.0021.0041.00122.00704.00144.00101.00148.00
Return on Equity Growth (3y) -705.00-73.00-17.00-61.0014.0051.00118.00174.00
Return on Equity (QoQ) -36.0011.00-1.0011.00-1.00-43.00-54.00-159.00142.0046.00-126.00-496.00596.0066.00-45.0086.0036.0024.002.00
Return on Sales Growth (1y) -0.02M-0.04M0.04M0.04M0.01M
Return on Sales Growth (3y) -0.01M
Return on Sales (QoQ) 169.00-0.01M-0.04M0.03M0.04M0.01M-0.00M